Cargando…
Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer
Metabotropic glutamate receptors (mGluRs) are normally expressed in the central nervous system, where they mediate neuronal excitability and neurotransmitter release. Certain cancers, including melanoma and gliomas, express various mGluR subtypes that have been implicated as playing a role in diseas...
Autores principales: | Speyer, Cecilia L., Hachem, Ali H., Assi, Ali A., Johnson, Jennifer S., DeVries, John A., Gorski, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954556/ https://www.ncbi.nlm.nih.gov/pubmed/24633367 http://dx.doi.org/10.1371/journal.pone.0088830 |
Ejemplares similares
-
Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer
por: Sexton, Rachel E., et al.
Publicado: (2018) -
Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer
por: Banda, Malathi, et al.
Publicado: (2014) -
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
por: Maksymetz, James, et al.
Publicado: (2017) -
Targeting of Metabotropic Glutamate Receptors for the Development of
Novel Antidepressants
por: Chaki, Shigeyuki, et al.
Publicado: (2019) -
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
por: Wan, Zhuoya, et al.
Publicado: (2021)